Equity Research Services-General Medical & Surgical Hospitals, NEC

Should You Buy Community Health Systems, Inc. Stock in 2026?

By CirclFi Research Team · · 9/13 models active

According to the CirclFi Deep Alpha Valuation Engine, Community Health Systems, Inc. (CYH) occupies a solid middle-ground position with a Quality of Company score of 7.1/10. At the current market price of $3.12, the investment case depends heavily on whether our 13 independent valuation models indicate a discount to fair value.

The short answer: 6 of 9 CirclFi valuation models project upside for Community Health Systems, Inc. (CYH) at $3.12 — the model consensus leans bullish, with a Quality Score of 7.1/10 and Value-Trap risk of 18/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 6 of 9 models see upside — majority bullish
  • Quality Score: 7.1/10 — Strong — above-average quality
  • Value Trap Risk: 18/100 — Minimal — healthy fundamentals
  • Fair Value Range: $1.30 – $14.64 (1029% spread)

Bullish Models

6 / 9

Bearish Models

3 / 9

Quality Score

7.1 /10

Strong — above-average quality

Value Trap Risk

18 /100
Minimal

Minimal — healthy fundamentals

Model Consensus

9 /13
Active Models

Avg. confidence: 41%

Investment Thesis

The Bull Case

Target: $14.64 (+369.1% upside)

  • According to the CirclFi Quality of Company (QOC) framework, Community Health Systems, Inc.'s rating of 7.1/10 signals strong fundamentals — high-quality businesses tend to compound value more reliably.
  • According to the CirclFi Deep Alpha Valuation Engine, 6 of 9 models identify upside from $3.12 to a composite fair value of $9.00, indicating the market hasn't fully priced in Community Health Systems, Inc.'s earnings power.
  • According to the CirclFi Deep Alpha Valuation Engine, the Markov DDM model targets a fair value of $14.64 (+369.1%), anchoring the bull case with a methodology that provides a differentiated analytical lens.

The Bear Case

Target: $1.30 (-58.5%)

  • According to the CirclFi Deep Alpha Valuation Engine, the First Chicago model sees the stock as overvalued with a fair value of $1.30 (-58.5%), suggesting that the market price embeds overly optimistic growth assumptions.
  • According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +427.5% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology.

Peer Benchmarking

ARDT Ardent Health, Inc.
9.1
UHS Universal Health Ser
9.0
HCA HCA Healthcare, Inc.
8.2
THC Tenet Healthcare Cor
8.1
SGRY Surgery Partners, In
6.4

Valuation Divergence

Spread

1029%

Fair Value Range

$1.30 – $14.64

A 1029% spread signals high uncertainty. The investment outcome depends heavily on which scenario plays out.

Most Bullish

Markov DDM

$14.64 (+369.1%)

Most Bearish

First Chicago

$1.30 (-58.5%)

Key Risk Factors

Model Disagreement

1029% spread signals high variance in projections.

Macro/Sector Risk

Services-General Medical & Surgical Hospitals, NEC headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View CYH Data Page →

The Bottom Line

Community Health Systems, Inc. leans positive in our analysis — 6/9 models bullish, composite fair value of $9.00 vs. $3.12, QOC 7.1/10. The case is constructive but not overwhelming, and the 3 dissenting models shouldn't be dismissed. Position sizing should reflect this moderate conviction level.

These are quantitative model outputs, not investment recommendations. Community Health Systems, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

Frequently Asked Questions

Should I buy CYH stock right now?

Based on CirclFi's multi-model analysis, 6 of 9 models see upside for CYH at $3.12. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 7.1/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in Community Health Systems, Inc.?

Key risks include: wide model disagreement (1029% spread), signaling high uncertainty; general market and sector-specific risks affecting Services-General Medical & Surgical Hospitals, NEC companies. Always diversify and consult a financial advisor.

How does CYH compare to its competitors?

Among Services-General Medical & Surgical Hospitals, NEC peers, CYH holds a Quality Score of 7.1/10. Comparable companies include ARDT (QOC 9.1), UHS (QOC 9.0), HCA (QOC 8.2). The relative ranking helps investors identify whether CYH offers better fundamental quality than alternatives in the same sector.

Is CYH a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. CYH's Quality Score of 7.1/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.

What price should I buy CYH at?

CirclFi does not provide target buy prices or price alerts. However, our 9 active models produce fair value estimates ranging from $1.30 to $14.64. At $3.12, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for CYH.

View CYH Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →